982 related articles for article (PubMed ID: 21270815)
41. L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
Aritomi S; Konda T; Yoshimura M
Heart Vessels; 2012 Jul; 27(4):419-23. PubMed ID: 21989861
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
[TBL] [Abstract][Full Text] [Related]
43. Renoprotective effect of N-type Ca channel blockade in diabetic nephropathy.
Fujisawa T; Ikegami H; Noso S; Hiromine Y; Kawabata Y; Nishino M; Asano K; Ogihara T
J Diabetes Complications; 2007; 21(4):252-7. PubMed ID: 17616356
[TBL] [Abstract][Full Text] [Related]
44. Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Ma SK; Kim SW
Hypertens Res; 2010 Mar; 33(3):255-62. PubMed ID: 20057489
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
Ando K; Ueshima K; Tanaka S; Kosugi S; Sato T; Matsuoka H; Nakao K; Fujita T
Int J Med Sci; 2013; 10(9):1209-16. PubMed ID: 23935398
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
[TBL] [Abstract][Full Text] [Related]
47. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
48. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
[TBL] [Abstract][Full Text] [Related]
49. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
[TBL] [Abstract][Full Text] [Related]
50. Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
Masaki M; Mano T; Eguchi A; Fujiwara S; Sugahara M; Hirotani S; Tsujino T; Komamura K; Koshiba M; Masuyama T
Heart Vessels; 2016 Nov; 31(11):1826-1833. PubMed ID: 26825736
[TBL] [Abstract][Full Text] [Related]
51. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
[TBL] [Abstract][Full Text] [Related]
53. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
Nagasu H; Satoh M; Fujimoto S; Tomita N; Sasaki T; Kashihara N
Hypertens Res; 2012 Mar; 35(3):348-55. PubMed ID: 22072106
[TBL] [Abstract][Full Text] [Related]
54. Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.
Takai S; Jin D; Aritomi S; Niinuma K; Miyazaki M
Hypertens Res; 2013 Apr; 36(4):342-8. PubMed ID: 23190689
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of the renal renin-angiotensin system and renoprotection by pitavastatin in type1 diabetes.
Toba H; Mitani T; Takahashi T; Imai N; Serizawa R; Wang J; Kobara M; Nakata T
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1064-70. PubMed ID: 20678154
[TBL] [Abstract][Full Text] [Related]
56. L-/N-type calcium channel blockers and proteinuria.
Ando K
Curr Hypertens Rev; 2013 Aug; 9(3):210-8. PubMed ID: 24479751
[TBL] [Abstract][Full Text] [Related]
57. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase.
Jiménez R; López-Sepúlveda R; Kadmiri M; Romero M; Vera R; Sánchez M; Vargas F; O'Valle F; Zarzuelo A; Dueñas M; Santos-Buelga C; Duarte J
Free Radic Biol Med; 2007 Aug; 43(3):462-73. PubMed ID: 17602962
[TBL] [Abstract][Full Text] [Related]
58. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
[TBL] [Abstract][Full Text] [Related]
59. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
Gunduz Z; Dursun N; Akgun H; Ozturk F; Okur H; Koc N
Regul Pept; 2005 Dec; 132(1-3):59-66. PubMed ID: 16229907
[TBL] [Abstract][Full Text] [Related]
60. Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes.
Chen J; Gu Y; Lin F; Yang H; Zhu W; Ma J; Lin S
Chin Med J (Engl); 2002 Jul; 115(7):972-8. PubMed ID: 12150723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
